These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 6278935)
21. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Fu X; Guadagni F; Hoffman RM Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5645-9. PubMed ID: 1608975 [TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Kaighn ME; Narayan KS; Ohnuki Y; Lechner JF; Jones LW Invest Urol; 1979 Jul; 17(1):16-23. PubMed ID: 447482 [TBL] [Abstract][Full Text] [Related]
23. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells. Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448 [TBL] [Abstract][Full Text] [Related]
24. Cell line derived from a metastasis of a human testicular germ cell tumor. Bronson DL; Andrews PW; Solter D; Cervenka J; Lange PH; Fraley EE Cancer Res; 1980 Jul; 40(7):2500-6. PubMed ID: 7388807 [TBL] [Abstract][Full Text] [Related]
25. Establishment and characterization of primary human pancreatic carcinoma in continuous cell culture and in nude mice. Grant AG; Duke D; Hermon-Taylor J Br J Cancer; 1979 Feb; 39(2):143-51. PubMed ID: 435363 [TBL] [Abstract][Full Text] [Related]
26. Progressive development of gap junctions during growth of human pancreatic duct cells (Capan-1) in vitro and in vivo. Monzat V; Fanjul M; Leclerc C; Palévody C; Briand JP; Jarry-Guichard T; Gabrion J; Moreau M; Hollande E Biol Cell; 1995; 85(2-3):157-65. PubMed ID: 8785517 [TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of SUIT-58 pancreas cancer cell line and its subline S58-SF adapted to serum-free condition derived from metastatic liver tumor. Takahashi N; Aoyama F; Ohuchida J; Sameshima N; Asada Y; Sawaguchi A Hum Cell; 2015 Oct; 28(4):190-8. PubMed ID: 26141632 [TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusion. Starr AN; Vexler A; Marmor S; Konik D; Ashkenasi-Voghera M; Lev-Ari S; Greif Y; Ben-Yosef R Oncology; 2005; 69(3):239-45. PubMed ID: 16141719 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a human endometrial carcinoma cell line producing intraperitoneal tumor growth in immunodeficient mice. Rubin SC; Federici MG; Lloyd KO; Lewis JL; Hoskins WJ Gynecol Oncol; 1992 Jun; 45(3):273-8. PubMed ID: 1612503 [TBL] [Abstract][Full Text] [Related]
30. Characterization of an ovarian carcinoma cell line. Freedman RS; Pihl E; Kusyk C; Gallager HS; Rutledge F Cancer; 1978 Nov; 42(5):2352-9. PubMed ID: 719612 [TBL] [Abstract][Full Text] [Related]
31. Sensitivity of xenografts of human pancreatic adenocarcinoma in nude mice to heat and heat combined with chemotherapy. Shiu MH; Cahan A; Fogh J; Fortner JG Cancer Res; 1983 Sep; 43(9):4014-8. PubMed ID: 6409393 [TBL] [Abstract][Full Text] [Related]
32. Characterization of six cell lines established from human pancreatic adenocarcinomas. Kato M; Shimada Y; Tanaka H; Hosotani R; Ohshio G; Ishizaki K; Imamura M Cancer; 1999 Feb; 85(4):832-40. PubMed ID: 10091760 [TBL] [Abstract][Full Text] [Related]
33. Distinction of the phenotypes of in vitro anchorage-independent soft-agar growth and in vivo tumorigenicity in the nude mouse. Dodson MG; Slota J; Lange C; Major E Cancer Res; 1981 Apr; 41(4):1441-6. PubMed ID: 7011536 [TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of a novel human pancreatic cancer cell line (SUIT-4) metastasizing to lymph nodes and lungs in nude mice. Kawano K; Iwamura T; Yamanari H; Seo Y; Suganuma T; Chijiiwa K Oncology; 2004; 66(6):458-67. PubMed ID: 15452375 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (AsPC-1) implanted orthotopically into nude mice. Tan MH; Chu TM Tumour Biol; 1985; 6(1):89-98. PubMed ID: 4023565 [TBL] [Abstract][Full Text] [Related]
36. Structural analysis of a new highly metastatic cell line PaTu 8902 from a primary human pancreatic adenocarcinoma. Elsässer HP; Lehr U; Agricola B; Kern HF Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):201-7. PubMed ID: 8287116 [TBL] [Abstract][Full Text] [Related]
37. Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation. Kim YW; Kern HF; Mullins TD; Koriwchak MJ; Metzgar RS Pancreas; 1989; 4(3):353-62. PubMed ID: 2734279 [TBL] [Abstract][Full Text] [Related]
38. Response of nude mouse-grown adenocarcinomas of the human exocrine pancreas to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride. Kyriazis AP; Kyriazis AA; Yagoda A; Fogh J Cancer Res; 1985 Sep; 45(9):4354-9. PubMed ID: 3896479 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764 [TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]